Kimball Electronics Navigates Headwinds, Eyes Medical CMO Growth

Ticker: KE · Form: DEF 14A · Filed: Sep 25, 2025 · CIK: 1606757

Kimball Electronics, Inc. DEF 14A Filing Summary
FieldDetail
CompanyKimball Electronics, Inc. (KE)
Form TypeDEF 14A
Filed DateSep 25, 2025
Risk Levelmedium
Pages15
Reading Time18 min
Key Dollar Amounts$12 million, $250 billion, $4.5 billion
Sentimentmixed

Sentiment: mixed

Topics: Electronics Manufacturing, Medical Devices, Contract Manufacturing, Strategic Divestiture, Debt Reduction, Share Repurchase, Corporate Governance, Proxy Statement, Supply Chain

Related Tickers: KE, NVRI, BHC, ALB, SYNT, ESE, MTRN

TL;DR

**KE is shedding non-core assets and doubling down on high-margin medical manufacturing; expect a bumpy but ultimately profitable ride as they execute this pivot.**

AI Summary

Kimball Electronics, Inc. (KE) reported its third-highest annual revenue in its 60+ year history for fiscal year 2025, with 75% derived from long-standing customer relationships. The company achieved an all-time best in cash generated from operating activities and reduced its debt to a three-year low. KE returned $12 million to share owners through share repurchases. Despite these achievements, the company faced a challenging operating environment, including prolonged demand softness and the loss of two major programs. Strategic changes included the divestiture of the non-core Automation, Test, and Measurement business and the closure of its Tampa facility to streamline operations and leverage low-cost regions. Kimball Electronics is focusing on high-complexity, high-reliability programs, particularly in the medical Contract Manufacturing Organization (CMO) space, with a new 300,000-square-foot facility in Indianapolis to expand capabilities in areas like cold chain management and complete device assembly. The company anticipates positive topline growth in fiscal year 2027.

Why It Matters

Kimball Electronics' strategic pivot towards high-margin medical CMO, evidenced by its new Indianapolis facility and sole supplier status for a major medical customer, signals a significant shift in its business model. This focus on a highly regulated, complex sector could enhance profitability and diversify revenue, offering investors a clearer growth trajectory beyond traditional electronics manufacturing services. For employees, this means a reallocation of resources and potential job growth in specialized medical manufacturing, while customers benefit from a more focused and capable partner in critical healthcare equipment. In a competitive landscape, this specialization could give Kimball a distinct advantage, positioning it as a premium provider in a vital industry.

Risk Assessment

Risk Level: medium — The company acknowledges a 'challenging operating environment' with 'prolonged demand softness' and the 'loss of two major programs,' which significantly impacted operations. While strategic divestitures and facility closures aim to streamline, these actions also carry execution risks and potential for further disruption, justifying a medium risk assessment.

Analyst Insight

Investors should monitor Kimball Electronics' execution of its medical CMO strategy, particularly the ramp-up of the Indianapolis facility and new customer wins. The $12 million in share repurchases and debt reduction indicate financial discipline, but future top-line growth, projected for fiscal year 2027, is key to validating the strategic shift.

Financial Highlights

debt To Equity
X.X
revenue
$X
operating Margin
X%
total Assets
$X
total Debt
$X
net Income
$X
eps
$X
gross Margin
X%
cash Position
$X
revenue Growth
+X%

Executive Compensation

NameTitleTotal Compensation
None ProvidedNamed Executive Officers$X

Key Numbers

  • $12 million — Share Repurchases (Amount returned to Share Owners in fiscal year 2025)
  • 75% — Revenue from long-term customers (Percentage of fiscal year 2025 revenue from customers of a decade or more)
  • 3 years — Debt reduction (Lowest debt level in 3 years achieved in fiscal year 2025)
  • 15-year high — Quality ratings (Achieved in fiscal year 2025)
  • 300,000-square-foot — New facility size (Medical CMO facility in Indianapolis)
  • 99.999% — Reliability standard (Internal 'five 9s' reliability standard)
  • 2027 — Anticipated positive topline growth (Fiscal year when positive topline growth is anticipated)
  • 24,387,270 — Shares outstanding (As of September 15, 2025 Record Date)
  • November 14, 2025 — Annual Meeting Date (Date of the 2025 Annual Meeting of Share Owners)
  • September 15, 2025 — Record Date (Date for voting eligibility at the Annual Meeting)

Key Players & Entities

  • Kimball Electronics, Inc. (company) — Registrant
  • Ric Phillips (person) — Chief Executive Officer and Director
  • Douglas A. Hass (person) — Chief Legal & Administrative Officer, Secretary
  • Michele A. M. Holcomb, PhD (person) — Director nominee, former EVP at Cardinal Health
  • Tom G. Vadaketh (person) — Director nominee, CFO at Enviri Corporation
  • Holly A. Van Deursen (person) — Director nominee, independent director for Albemarle Corporation and Synthomer, plc
  • Robert J. Phillippy (person) — Chairperson of the Board
  • Deloitte & Touche LLP (company) — Independent Registered Public Accounting Firm
  • SEC (regulator) — Securities and Exchange Commission
  • Indianapolis (location) — Location of new medical CMO facility and annual meeting

FAQ

What were Kimball Electronics' key financial achievements in fiscal year 2025?

In fiscal year 2025, Kimball Electronics achieved its third-highest annual revenue in its 60+ year history, recorded an all-time best in cash generated from operating activities, and paid down its debt to its lowest level in 3 years. The company also returned $12 million to share owners through share repurchases.

What strategic changes did Kimball Electronics implement in fiscal year 2025?

Kimball Electronics completed the divestiture of its non-core Automation, Test, and Measurement business and announced the closure of its Tampa facility. These actions were taken to streamline the network, improve global capacity utilization, and align its U.S. electronics manufacturing footprint with market demand.

What is Kimball Electronics' strategy for growth in the medical sector?

Kimball Electronics' strategy is to pursue growth in the medical Contract Manufacturing Organization (CMO) space with blue-chip customers, focusing on high-complexity, high-reliability programs. This includes expanding capabilities at its new 300,000-square-foot Indianapolis facility for cold chain management, complete device assembly, and precision-molded plastics.

When is Kimball Electronics' 2025 Annual Meeting of Share Owners?

The 2025 Annual Meeting of Share Owners for Kimball Electronics, Inc. will be held on Friday, November 14, 2025, at 10:00 A.M. Eastern Standard Time (EST) at the company's new Indianapolis facility located at 1220 South Post Road, Indianapolis, Indiana.

Who are the director nominees for election at the Kimball Electronics 2025 Annual Meeting?

The Class II nominees for election as directors at the 2025 Annual Meeting, serving a three-year term, are Michele Holcomb, Tom Vadaketh, and Holly Van Deursen. Each nominee brings significant experience in strategy, finance, and global manufacturing.

What are the key proposals for share owner vote at the Kimball Electronics Annual Meeting?

Share owners will vote on three main proposals: the election of three directors (Proposal 1), the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2026 (Proposal 2), and an advisory vote on the compensation paid to Named Executive Officers (Proposal 3).

How does Kimball Electronics oversee risk, including cybersecurity?

Kimball Electronics' Board of Directors oversees risk through various committees, with specific roles outlined in their charters. Cybersecurity/Information Security oversight is a key area, ensuring the company addresses potential threats to its operations and data.

What is the significance of Kimball Electronics' new Indianapolis facility?

The new 300,000-square-foot medical CMO facility in Indianapolis is a critical milestone in Kimball Electronics' strategy to expand production capabilities in areas like cold chain management, complete device assembly, and precision-molded plastics, supporting growth in the medical market.

What is Kimball Electronics' outlook for topline growth?

Kimball Electronics expects fiscal year 2026 to be another step forward in its strategic journey and anticipates positive topline growth in fiscal year 2027, driven by its focus on the medical CMO space and leveraging its core strengths.

What is the record date for voting at the Kimball Electronics 2025 Annual Meeting?

The record date for the Kimball Electronics 2025 Annual Meeting is the close of business on September 15, 2025. Only share owners of record on this date are entitled to notice of and to vote at the Annual Meeting.

Risk Factors

  • Loss of Major Programs [medium — operational]: The company experienced the loss of two major programs, which impacted its performance. The DEF 14A does not specify the financial impact of these losses but highlights them as a challenge in the operating environment.
  • Prolonged Demand Softness [medium — market]: Kimball Electronics faced a challenging operating environment characterized by prolonged demand softness. This indicates a broader market trend affecting the company's ability to generate revenue.
  • Facility Closure [low — operational]: The closure of the Tampa facility was a strategic decision to streamline operations and leverage low-cost regions. While intended to improve efficiency, facility closures can carry short-term disruption risks.
  • Debt Management [low — financial]: While the company reduced its debt to a three-year low, ongoing debt management remains a financial consideration. The specific debt levels and covenants are not detailed in this section.

Industry Context

Kimball Electronics operates in the electronics manufacturing services (EMS) industry, which is highly competitive and subject to global economic conditions. The industry is characterized by a need for high complexity, reliability, and cost-efficiency, particularly in sectors like medical devices. Trends include reshoring efforts, supply chain resilience, and increasing demand for specialized manufacturing capabilities.

Regulatory Implications

As a manufacturer, Kimball Electronics is subject to various regulations related to product safety, environmental standards, and labor practices. Compliance with these regulations is crucial to avoid penalties and maintain operational integrity. The company's focus on the medical CMO space also brings it under the purview of medical device manufacturing regulations.

What Investors Should Do

  1. Review Proposal 3: Advisory Vote on Executive Compensation
  2. Evaluate the company's strategic shift towards high-complexity, high-reliability programs, especially in the medical CMO space.
  3. Monitor the company's progress towards anticipated positive topline growth in fiscal year 2027.

Key Dates

  • 2025-11-14: 2025 Annual Meeting of Share Owners — Key decisions regarding director elections, auditor ratification, and executive compensation advisory vote are made.
  • 2025-09-15: Record Date for Annual Meeting — Determines which shareholders are eligible to vote at the annual meeting.
  • 2025-09-25: Mailing of Proxy Statement and Annual Report — Provides shareholders with information to make informed voting decisions.

Glossary

DEF 14A
A proxy statement filed by a public company with the U.S. Securities and Exchange Commission (SEC) when soliciting proxies from shareholders for an annual or special meeting. (This document contains critical information about the company's governance, executive compensation, and shareholder proposals.)
Named Executive Officers (NEOs)
The top executive officers of a company, typically including the CEO, CFO, and other highest-paid executives, whose compensation is detailed in the proxy statement. (Shareholders vote on executive compensation, making the compensation of NEOs a key focus.)
Record Date
A specific date set by a company to determine which shareholders are eligible to receive dividends, vote on corporate matters, or receive other distributions. (Establishes eligibility for voting at the Annual Meeting.)
Proxy Statement
A document that a company must provide to shareholders before a shareholder meeting, containing information about the matters to be voted on. (This is the primary document for shareholder engagement and voting.)
Contract Manufacturing Organization (CMO)
A company that provides manufacturing services to other companies, often in specialized industries like medical devices. (Kimball Electronics is strategically focusing on the medical CMO space, highlighting this as a growth area.)

Year-Over-Year Comparison

The DEF 14A indicates a mixed performance compared to the previous year. While revenue reached a third-highest annual record and debt was reduced to a three-year low, the company faced challenges like prolonged demand softness and the loss of major programs. Strategic divestitures and facility closures suggest efforts to improve operational efficiency and focus on core strengths, contrasting with potential growth initiatives from the prior period.

Filing Stats: 4,542 words · 18 min read · ~15 pages · Grade level 13.8 · Accepted 2025-09-25 11:53:27

Key Financial Figures

  • $12 million — west level in 3 years; and We returned $12 million to you, our Share Owners, through share
  • $250 billion — utive management roles for BP p.l.c., a $250 billion oil, gas, and energy company operating
  • $4.5 billion — Vice President and General Manager of a $4.5 billion global portfolio of HVAC product busine

Filing Documents

Executive Compensation

Executive Compensation 50 Summary Compensation Table 50 Grants of Plan-Based Awards in Fiscal Year 2025 51 Outstanding Equity Awards at Fiscal Year End 2025 53 Option Exercises and Stock Vested in Fiscal Year 2025 54 5 Nonqualified Deferred Compensation in Fiscal Year 2025 54 Employment Agreements with NEOs and Potential Payments Upon Termination or Change-In-Control 55 CEO Pay Ratio 57 Pay vs. Performance of our NEOs 57 Equity Compensation Plans Information 61 Proposal 3: Advisory Vote on the Compensation Paid to Our Named Executive Officers 61 Share Ownership Information 63 Information About the 2025 Annual Meeting 65 Other Matters 69 Submission of Nominations and Proposals For 2026 69 Communication with the Board 70 Appendix A: Pre-Approval Process for Services Performed by the Independent Registered Public Accounting Firm A- 1 6 SUMMARY OF INFORMATION ABOUT THE ANNUAL MEETING Annual Share Owners Meeting DATE November 14, 2025 TIME 10:00 a.m. EST PLACE 1220 South Post Road, Indianapolis, Indiana 46329 RECORD DATE September 15, 2025 VOTING ELIGIBILITY Registered Share Owners as of the Record Date are entitled to submit proxies or vote in person at the Annual Share Owners Meeting. Solicitation of Proxies The Board of Directors (also referred to herein as the "Board") of Kimball Electronics, Inc. ("we," "us," "our," "Kimball Electronics," or the "Company") is soliciting proxies for use at the Company's 2025 Annual Meeting of Share Owners and any postponements or adjournments of that meeting (as so postponed or adjourned, the "2025 Annual Meeting" or the "Annual Meeting"). The Company first mailed this Proxy Statement, the accompanying form of proxy, and the Company's Annual Report for 2025 on or about September 25, 2025. The Board has fixed the close of business on September 15, 2025 as the Record Date for the Annual Meeting. You are entitled to notice and to vote if you were a Share Owner of reco

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.